David L. Lucchino, CEO of Cambridge-based Semprus BioSciences, has been elected to the board of directors of the trade association Advanced Medical Technology Association (AdvaMed).

AdvaMed represents about 400 medical device and diagnostics manufacturers on legal, regulatory and economic issues. Based in Washington D.C., the association says that it promotes policies that foster high ethical standards, rapid product approvals, appropriate reimbursement and international market access.